Jan 13, 2023 / Presentations

Medicare Part D: Status report

Research Areas:

Drugs, Devices, and Tests, Medicare Spending and Financing, Quality

Sep 29, 2022 / Transcripts

September 29-30, 2022 meeting transcripts

Research Areas:

Beneficiaries and Coverage, Drugs, Devices, and Tests, Hospitals, Physicians And Other Health Professionals, Post-Acute Care, Quality

Sep 29, 2022 / Presentations

Analysis of Part D data on drug rebates and discounts

Research Areas:

Drugs, Devices, and Tests, Medicare Spending and Financing

Jun 15, 2022 / Reports

June 2022 Report to the Congress: Medicare and the Health Care Delivery System

Research Areas:

Ambulatory Care Settings, Beneficiaries and Coverage, Delivery System Reforms, Drugs, Devices, and Tests, Hospitals, Physicians And Other Health Professionals, Post-Acute Care, Private Plans, Quality, Regional Issues

Jun 15, 2022 / Chapters

Executive summary (June 2022 report)

Research Areas:

Ambulatory Care Settings, Beneficiaries and Coverage, Delivery System Reforms, Drugs, Devices, and Tests, Hospitals, Physicians And Other Health Professionals, Post-Acute Care, Private Plans, Quality, Regional Issues

Jun 15, 2022 / Chapters

Chapter 7: Segmentation in the stand-alone Part D plan market (June 2022 report)

Research Areas:

Beneficiaries and Coverage, Drugs, Devices, and Tests

Jun 15, 2022 / Chapters

Appendix A: Commissioners’ voting on recommendations (June 2022 report)

Research Areas:

Ambulatory Care Settings, Beneficiaries and Coverage, Delivery System Reforms, Drugs, Devices, and Tests, Hospitals, Physicians And Other Health Professionals, Private Plans, Quality, Regional Issues

Jun 15, 2022 / Press Releases

MedPAC releases June 2022 Report to the Congress: Medicare and the Health Care Delivery System

Research Areas:

Ambulatory Care Settings, Beneficiaries and Coverage, Delivery System Reforms, Drugs, Devices, and Tests, Hospitals, Physicians And Other Health Professionals, Private Plans, Quality, Regional Issues

Apr 07, 2022 / Presentations

Segmentation in the stand-alone Part D prescription drug plan market

Research Areas:

Drugs, Devices, and Tests

Apr 07, 2022 / Presentations

Initial findings from MedPAC’s analysis of Part D data on drug rebates and discounts

Research Areas:

Drugs, Devices, and Tests